Aberdeen Group’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-73,470
| Closed | -$739K | – | 904 |
|
|
2023
Q2 | $739K | Sell |
73,470
-73,177
| -50% | -$736K | ﹤0.01% | 811 |
|
|
2023
Q1 | $1.38M | Buy |
146,647
+44,369
| +43% | +$417K | ﹤0.01% | 765 |
|
|
2022
Q4 | $1.25M | Buy |
102,278
+7,595
| +8% | +$92.8K | ﹤0.01% | 752 |
|
|
2022
Q3 | $1.18M | Buy |
94,683
+39,647
| +72% | +$492K | ﹤0.01% | 766 |
|
|
2022
Q2 | $1.1M | Buy |
55,036
+3,161
| +6% | +$63.2K | ﹤0.01% | 775 |
|
|
2022
Q1 | $1.39M | Sell |
51,875
-10,509
| -17% | -$281K | ﹤0.01% | 786 |
|
|
2021
Q4 | $1.77M | Buy |
62,384
+5,717
| +10% | +$162K | ﹤0.01% | 799 |
|
|
2021
Q3 | $1.83M | Buy |
56,667
+8,675
| +18% | +$281K | ﹤0.01% | 798 |
|
|
2021
Q2 | $1.67M | Sell |
47,992
-3,158
| -6% | -$110K | ﹤0.01% | 803 |
|
|
2021
Q1 | $1.51M | Buy |
51,150
+6,201
| +14% | +$183K | ﹤0.01% | 808 |
|
|
2020
Q4 | $1.38M | Buy |
44,949
+4,368
| +11% | +$134K | ﹤0.01% | 799 |
|
|
2020
Q3 | $1.13M | Sell |
40,581
-11,545
| -22% | -$322K | ﹤0.01% | 783 |
|
|
2020
Q2 | $1.12M | Buy |
52,126
+2,499
| +5% | +$53.6K | ﹤0.01% | 769 |
|
|
2020
Q1 | $1.11M | Buy |
49,627
+565
| +1% | +$12.7K | ﹤0.01% | 751 |
|
|
2019
Q4 | $1.45M | Buy |
49,062
+5,044
| +11% | +$149K | ﹤0.01% | 757 |
|
|
2019
Q3 | $1.17M | Buy |
44,018
+2,346
| +6% | +$62.4K | ﹤0.01% | 779 |
|
|
2019
Q2 | $1.41M | Buy |
41,672
+3,124
| +8% | +$106K | ﹤0.01% | 787 |
|
|
2019
Q1 | $1.24M | Buy |
+38,548
| New | +$1.24M | ﹤0.01% | 786 |
|